16 January 2025 - In 2024, EMA recommended 114 medicines for marketing authorisation. 

Of these, 46 had a new active substance which had never been authorised in the European Union before. Among these are a number of medicines that stand out due to their contribution to address public health needs or the innovation they represent.

Read EMA press release